MedPath

Het monitoren van bijwerkingen van geneesmiddelen op de poliklinieken van GGZ Drenthe/Monitoring of side effects of medication at outpatient departments of Mental Health Services Drenthe

Recruiting
Conditions
psychiatrische aandoeningen/psychiatric diseases, metabool syndroom/metabolic syndrome, angststoornissen/anxiety disorders, stemmingsstoornissen/mood disorders
Registration Number
NL-OMON22977
Lead Sponsor
GGZ DrenthePostbus 300079400 RA Assen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
10000
Inclusion Criteria

In order to be eligible to participate in MOPHAR research, a subject must meet all of the following criteria:

• Visiting an outpatient department of MHS Drenthe (first time or follow-up visit);

Exclusion Criteria

In general, there are no exclusion criteria for inclusion in the MOPHAR cohort.

Study & Design

Study Type
Not specified
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The efficacy, (cost)effectiveness and safety of psychiatric pharmacotherapy (after implementation of a monitoring programme): <br /><br>- monitoring outcomes, such as antropometric examinations, blood parameters, etc. <br /><br>- score on psychiatric questionnaires<br /><br>- patient characteristics such as pharmacogenetics or biomarker levels<br /><br>- medication usage<br /><br>Specific primary and secondary study parameters will be determined for each individual research question.
Secondary Outcome Measures
NameTimeMethod
For example time (e.g. duration of psychotropic drug usage, duration of treatment at the outpatient department), costs, medication adherence, etc.
© Copyright 2025. All Rights Reserved by MedPath